The value of translational therapy in the treatment of advanced hepatoid adenocarcinoma of stomach

L. Chen; Jieli Xu; Jialin Li; Ke Ji; Ji Zhang; Xiaojiang Wu; Kai Zhou; Jiatian Tang; Yan Wu; Anqiang Wang; Zhaode Bu

doi:10.1186/s12885-025-15442-9

Abstract

Translational therapy is a promising strategy for patients with initially unresectable advanced hepatoid adenocarcinoma of stomach. Achieving R0 resection and attaining pathological complete remission are crucial milestones in improving patient prognosis.

Affiliated Institutions

Peking University Cancer Hospital CN

Related Publications

Preoperative Systemic Chemoimmunotherapy and Sequential Resection for Unresectable Hepatocellular Carcinoma

W. Y. Lau , Thomas Leung , Bo-san Lai +4 more

Combined modalities with systemic chemoimmunotherapy and surgical resection can achieve complete clinical remission and long-term control of disease in patients with unresectabl...

2001 Annals of Surgery 135 citations

Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction

John S. Macdonald , Stephen R. Smalley , Jacqueline Benedetti +8 more

Postoperative chemoradiotherapy should be considered for all patients at high risk for recurrence of adenocarcinoma of the stomach or gastroesophageal junction who have undergon...

2001 New England Journal of Medicine 3478 citations

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

Justin S. Waters , A. Norman , David Cunningham +12 more

We report the final results of a prospectively randomized study that compared the combination of epirubicin, cisplatin and protracted venous infusion fluorouracil (5-FU) (ECF re...

1999 British Journal of Cancer 278 citations

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

Thierry Gorlia , Martin J. van den Bent , Monika E. Hegi +9 more

A randomised trial published by the European Organisation for Research and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) Clinical Trials Group (...

2007 The Lancet Oncology 539 citations

<i>MGMT</i> Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

Giovanni Tallini , Roberta Bertorelle , Stefania Bartolini +11 more

Purpose Standard therapy for glioblastoma (GBM) is temozolomide (TMZ) administration, initially concurrent with radiotherapy (RT), and subsequently as maintenance therapy. The r...

2008 Journal of Clinical Oncology 814 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

The value of translational therapy in the treatment of advanced hepatoid adenocarcinoma of stomach

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    L. Chen, 
                                
                                    Jieli Xu, 
                                
                                    Jialin Li
                                
                                et al.
                            
                            (2025). 
                            The value of translational therapy in the treatment of advanced hepatoid adenocarcinoma of stomach. 
                            BMC Cancer
                            
                            .
                            https://doi.org/10.1186/s12885-025-15442-9

Identifiers

DOI: 10.1186/s12885-025-15442-9